GRIDS 2022 will focus on the latest advances, technological breakthroughs and novel therapies that are changing the landscape in LSDs. The intent of GRIDS 2022 is to further the discussion about the role of cell signaling, metabolite regulation, inflammatory and other pathways not only to understand the disease process in LSDs, but also to develop new diagnostics and treatment strategies.

GRIDS 2022 presentations will cover the topics related but not limited to the following disorders:

·         Fabry disease

·         Gaucher disease

·         Pompe disease

·         Tay-Sachs and Krabbe diseases

·         Mucopolysaccharidosis  (MPS) I, MPS II, MPS IV, MPS VI, MPS VII

·         GM1 & GM2 Gangliosidoses

·         Metachromatic Leukodystrophy

·         Mucolipidosis

·         Neimann Pick A/B diseases and Neimann Pick C disease

·         Sialidosis